Skip to main content

Proactive news headlines including Endeavour Mining, PayPal, Alternus Energy, Phunware, Todos Medical and Orgenesis

New York, Aug. 23, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

  • PayPal launches crypto service in the UK click here
  • Barclays sees upside for catalyst-rich Endeavour Mining click here
  • Canada Silver Cobalt Works hits high-grade intercepts at the Big Silver zone on its Castle East property click here
  • Alternus Energy appoints corporate governance veteran Tone Bjørnov to its board of directors  click here
  • DGTL Holdings subsidiary opens in Asia Pacific; signs largest airline in that market  click here
  • Phunware teams up with access control technology firm HID Global to help facilitate a safe return to the office  click here
  • Western Magnesium begins testing on new continuous pilot reactor ahead of schedule  click here
  • Atlas Engineered Products sees record 2Q revenue and profits on organic growth and efficiency initiatives  click here
  • Todos Medical poised to launch its cPass blood test in September this year to aid booster jab coronavirus battle  click here
  • Ketamine One establishes Medical Advisory Board  click here
  • Bragg’s ORYX Gaming strengthens its presence in Greece after taking content live with Novibet  click here
  • Orgenesis strikes collaboration agreement with Savicell Diagnostics to advance its cell and gene therapy platform  click here
  • GlobeX Data closes its C$5.7M oversubscribed financing; increases media exposure on Newsmax  click here
  • Versus partners with nine NFL teams to offer incentivized fan experiences  click here
  • Nomad Royalty Company announces major milestone as company is set to list on New York Stock Exchange  click here
  • O3 Mining promotes two of its executives to boost senior management; inks market-making services deal  click here
  • Zynerba Pharmaceuticals stock “presents a potentially significant opportunity for patient investors,” says Canaccord Genuity click here
  • RedHill Biopharma says USPTO has issued it with two new patents for opaganib for Ebola Virus and RHB-104 for Crohn’s click here

About Proactive 

With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives engage intelligently with investors.

Proactive’s platform delivers the right message to the right audience, digitally and in real time, leveraging a range of media, investment research, digital investor targeting and website development services to support over 1,000 fast-growing companies globally.

Proactive’s network reaches over 12 million engaged private, professional and institutional investors looking for opportunities.

• Our written and video content is published on Proactive sites that collectively attract up to 10 million views per month.

• We syndicate our content to hundreds of mainstream and specialist news sites that expand our reach into networks that can be difficult for press releases to penetrate.

• We custom build corporate websites from the ground up, empowering clients and their brands with a modern online presence and the latest insight on effective SEO strategy

• Our news coverage ranks high on the world’s most popular search platforms, and we can further amplify online presence and outreach with sophisticated digital investor targeting.

• We help the world understand what makes companies stand out from the crowd with in-depth investment research from a team of experienced analysts.

 For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com

 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.